IVX.AX
Invion Ltd
Price:  
0.08 
AUD
Volume:  
81,879.00
Australia | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IVX.AX EV/EBITDA

-395.7%
Upside

As of 2025-05-21, the EV/EBITDA ratio of Invion Ltd (IVX.AX) is -0.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IVX.AX's latest enterprise value is 5.62 mil AUD. IVX.AX's TTM EBITDA according to its financial statements is -5.96 mil AUD. Dividing these 2 quantities gives us the above IVX.AX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.6x - 9.3x 8.6x
Forward P/E multiples 4.5x - 7.5x 5.7x
Fair Price (0.57) - 0.22 (0.24)
Upside -797.5% - 165.7% -395.7%
0.08 AUD
Stock Price
(0.24) AUD
Fair Price

IVX.AX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-14 -1.16
2025-05-13 -1.18
2025-05-12 -1.18
2025-05-09 -1.15
2025-05-08 -1.15
2025-05-07 -1.16
2025-05-06 -1.15
2025-05-05 -1.15
2025-05-02 -1.18
2025-05-01 -1.15
2025-04-30 -1.18
2025-04-29 -1.18
2025-04-28 -1.31
2025-04-24 -1.18
2025-04-23 -1.18
2025-04-22 -1.15
2025-04-17 -1.15
2025-04-16 -1.24
2025-04-15 -1.14
2025-04-14 -1.18
2025-04-11 -1.18
2025-04-10 -1.18
2025-04-09 -1.14
2025-04-08 -1.14
2025-04-07 -1.24
2025-04-04 -1.24
2025-04-03 -1.24
2025-04-02 -1.37
2025-04-01 -1.37
2025-03-31 -1.18
2025-03-28 -1.24
2025-03-27 -1.31
2025-03-26 -1.37
2025-03-25 -1.44
2025-03-24 -1.31
2025-03-21 -1.50
2025-03-20 -1.50
2025-03-19 -1.44
2025-03-18 -1.50
2025-03-17 -1.50
2025-03-14 -1.44
2025-03-13 -1.31
2025-03-12 -1.18
2025-03-11 -1.24
2025-03-10 -1.50
2025-03-07 -1.63
2025-03-06 -1.57
2025-03-05 -1.63
2025-03-04 -1.70
2025-02-27 -1.70